BioReperia
Accelerating drug discovery and predicting the best cancer treatment for you!
19 employees · est. 2015 · Linkoping, Sweden
Immunai
Mapping the Immune System with AI to Improve Health
174 employees · est. 2019 · New York, United States
BioReperia is the older company (2015 vs 2019); Immunai is the larger of the two.
8 signals in the last 90 days
Side-by-Side Comparison
| Metric | BioReperia | Immunai |
|---|---|---|
| Founded | ||
| Founded | 2015 older | 2019 |
| Headquarters | ||
| Headquarters | Linkoping, Sweden | New York, United States |
| Employees | ||
| Employees | 19 | 174 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Life Sciences | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series A | Series B |
| Total Funding | ||
| Total Funding | $8.00M | $300.50M |
| Funding Rounds | ||
| Funding Rounds | 2 | 5 |
| Services | ||
| Services | Not tracked yet | Target Discovery, Preclinical Evaluation, Clinical Trial Optimization, Data Generation, Data Augmentation, Compute and Validate Therapeutic Insights, Recommendation Engine |
| Target Customers | ||
| Target Customers | Not tracked yet | biopharmaceutical companies, research institutions, pharma companies |
| Taxonomy | ||
| Taxonomy | Drug Discovery, Precision Medicine, Cancer Treatment, Zebrafish Models, Contract Research Organization, In Vivo Model, Tumor Xenograft, Metastasis Inhibition, Immuno-therapies, Patient-derived Xenografts, Swedish Biotech, Oncology Research, Bioinformatics, Biomedical Innovation | Immune System Mapping, Single-cell Genomics, Biotech, Therapeutic Discoveries, Drug Development, Patient Outcomes, Biomarker Discovery, High-resolution Profiling, Immune Profiling, Cellular Response Analysis, Cancer Research, Genomic Technologies, High-dimensional Statistics, Single-cell Biology |
| Website | ||
| Website | bioreperia.com | immunai.com |
About BioReperia
BioReperia is a Swedish startup that is revolutionizing the fields of drug discovery and cancer treatment with its unique ZTX® platform (zebrafish tumor xenograft). The company's slogan, "Accelerating drug discovery and predicting the best cancer treatment for you!", encapsulates its mission to pers...
About Immunai
Immunai, founded in 2019, is a United States-based startup that is revolutionizing the Biotechnology and Pharmaceutical industries with its innovative approach. The company's slogan, "Mapping the Immune System with AI to Improve Health," reflects its mission to map and decode the immune system using...
We will tell you when either one moves
BounceWatch watches BioReperia and Immunai for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at BioReperia and Immunai — by email.
Frequently Asked Questions
Compare BioReperia with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at BioReperia on 12 Sep 2024, and Immunai on 3 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.